Koninklijke DSM NV (DSM.AS)
-Amsterdam 49.15 
0.22(0.45%) 11:36AM EDT
| Prev Close: | 48.93 |
|---|
| Open: | 48.80 |
|---|
| Bid: | 49.06 |
|---|
| Ask: | 49.18 |
|---|
| 1y Target Est: | 45.73 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 47.82 - 49.49 |
|---|
| 52wk Range: | 36.42 - 50.02 |
|---|
| Volume: | 1,554,243 |
|---|
| Avg Vol (3m): | 893,753 |
|---|
| Market Cap: | N/A |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in EUR.
Headlines
- Q1 2013 Koninklijke DSM NV Earnings Release - 01:15 am ETCCBN(Thu 7:07AM EDT)
- DSM’s Costs Purge May Boost Profit by 120 Million Euros in 2013at Bloomberg(Thu 2:51AM EDT)
- DSM reports good start to the year in challenging environmentMarketwired(Thu 1:30AM EDT)
- DSM reports good start to the year in challenging environmentThomson Reuters ONE(Thu 1:17AM EDT)
- DSM and Republic of Tatarstan sign MOU for fortified nutritionMarketwired(Mon, Apr 8)
- DSM and Rostekhnologii to cooperate on biotechnology and functional materialsMarketwired(Mon, Apr 8)
- DSM and Republic of Tatarstan sign MOU for fortified nutritionThomson Reuters ONE(Mon, Apr 8)
- DSM and Rostekhnologii to cooperate on biotechnology and functional materialsThomson Reuters ONE(Mon, Apr 8)
- Leading nutrition organizations issue call to prioritize child nutrition for a healthier, more prosperous AsiaMarketwired(Mon, Apr 8)
- Leading nutrition organizations issue call to prioritize child nutrition for a healthier, more prosperous AsiaThomson Reuters ONE(Mon, Apr 8)
- DSM completes acquisition of TortugaMarketwired(Mon, Apr 8)
- DSM completes acquisition of TortugaThomson Reuters ONE(Mon, Apr 8)
- Novozymes to Boost R&D in Bioagriculture, Biofuel Race, CEO Saysat Bloomberg(Mon, Mar 18)
- DSM - proposed appointment to the Managing Board of DirectorsMarketwired(Thu, Mar 14)
- DSM - proposed appointment to the Managing Board of DirectorsThomson Reuters ONE(Thu, Mar 14)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-11)
: | N/A |
|---|
| Quarterly EPS Est
(Dec-11)
: | N/A |
|---|
| Mean Recommendation*: | 1.8 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
No business summary available forDSM.AS.